Miravant Medical Technologies engages in the research and development of photodynamic therapy (PDT), a treatment modality based on drugs that respond to light. When activated by light, these drugs induce a photochemical reaction in the presence of oxygen that can be used to locally destroy diseased cells and abnormal blood vessels. Products PHOTREX: This product is useful in treating wet age-related macular degeneration. This product entered the Phase III clinical trials. MV0633: This product is useful in atherosclerosis, vulnerable plaque, and restenosis. This product is in advanced preclinical stage. MV9411: This is used in treating plaque psoriasis. This product finished Phase II trials and it is under data analysis and evaluation. MV2101: This product is in the advanced preclincal stage and is used in the treatment of vascular access graft disease in hemodialysis patients. MV6401: This is in a preclinical trial and is used in treating solid tumors (treatment of cells and neovasculature, or new blood vessels). Light Producing Devices: The company’s PhotoPoint procedures are designed to use light producing devices. Its light technologies include software-controlled diode lasers, light emitting diode (LED), arrays, and non-coherent light sources. Either internally or with outside collaborators, the company has developed several devices producing various wavelengths of light for use in its investigational studies. The company is collaborating with Iridex Corporationon the development of light producing devices for PhotoPoint PDT in ophthalmology. Light Delivery Devices: The company has developed various configurations of fiber optic devices to deliver uniform light to target tissues, its proprietary guidewire-compatible endovascular light catheter that is being tested in preclinical studies for the treatment of cardiovascular disease. Competition The company’s competitors include QLT, Inc.; DUSA Pharmaceuticals; Axcan Pharm, Inc.; Eyetech Pharmacueticals, Inc.; Pharmacyclics; Genetech, Inc.; Alcon, Inc.; and Allergan, Inc. History Miravant Medical Technologies was incorporated in Delaware in 1989. The company was founded by Gary S. Kledzik. It was formerly known as PDT, Inc. and changed its name to Miravant Medical Technologies in 1997.
miravant medical technologie
7408 Hollister Avenue
Santa Barbara, CA 93117
|No competitor information is available for MRVT.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Post a JobJobs
- Detroit, MI | Wayne State UniversityPosted: Nov 26
- New York, NY | AGORAPosted: Nov 25
- Nevada | Walmart MilitaryPosted: Oct 24
- Asheville, NC | Mission HospitalsPosted: Dec 05
Sponsored Financial Commentaries
To contact MIRAVANT MEDICAL TECHNOLOGIE, please visit www.miravant.com. Company data is provided by Capital IQ. Please use this form to report any data issues.